Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|August 10, 2000
Use of PET in neuroendocrine tumors. In vivo applications and in vitro studiesB Eriksson, M Bergström, H Orlefors, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|March 15, 2005
Developments in PET for the detection of endocrine tumoursB Eriksson, H Orlefors, K Oberg, et al.
Italian Journal of Gastroenterology and Hepatology|December 22, 1999
Positron emission tomography in neuroendocrine tumoursB Eriksson, H Orlefors, A Sundin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 27, 2005
Carbidopa pretreatment improves image interpretation and visualisation of carcinoid tumours with 11C-5-hydroxytryptophan positron emission tomographyH Orlefors, A Sundin, L Lu, et al.
Nordisk Medicin|December 4, 1998
[PET in neuroendocrine tumors]B Eriksson, H Orlefors, A Sundin, et al.
Anticancer Research|April 19, 2000
Uptake of 14C- and 11C-labeled glutamate, glutamine and aspartate in vitro and in vivoF Wu, H Orlefors, M Bergström, et al.
Anticancer Research|July 1, 1997
Effect of 6-diazo-5-oxo-L-norleucine (DON) on human carcinoid tumor cell aggregatesF Wu, M Bergström, M Stridsberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Positron emission tomography with 5-hydroxytryprophan in neuroendocrine tumorsH Orlefors, A Sundin, H Ahlström, et al.
Pageof 1